![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A01N 41/10 | (2006.01) |
A61K 31/10 | (2006.01) | ||
A61P 39/00 | (2006.01) |
(11) | Number of the document | 2552199 |
(13) | Kind of document | T |
(96) | European patent application number | 11760239.1 |
Date of filing the European patent application | 2011-03-24 | |
(97) | Date of publication of the European application | 2013-02-06 |
(45) | Date of publication and mention of the grant of the patent | 2015-06-03 |
(46) | Date of publication of the claims translation | 2015-11-25 |
(86) | Number | PCT/US2011/029840 |
Date | 2011-03-24 |
(87) | Number | WO 2011/119863 |
Date | 2011-09-29 |
(30) | Number | Date | Country code |
318100 P | 2010-03-26 | US |
(72) |
MANIAR, Manoj, US
|
(73) |
Onconova Therapeutics, Inc.,
375 Pheasant Run, Newtown, PA 18940,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Pagerintos stabilios (e)-4-karboksistiril-4-chlorbenzilsulfono vandeninės kompozicijos |
IMPROVED STABLE AQUEOUS FORMULATION OF (E)-4-CARBOXYSTYRYL-4-CHLOROBENZYL SULFONE |
Payment date | Validity (years) | Amount | |
2024-03-04 | 14 | 289.00 EUR |
2025-03-24 |